Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 2/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | HTR5A | P47898 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2307937 | 0.83 | CES1 (0.60) | TGM2PDGFRBCES1MAOAMAOB | |
| SCHEMBL21708143 | 0.83 | MAOB (0.45) | TGM2CA1CA2CA7CA9 | |
| Nitrogen SCHEMBL29242346 | 0.80 | CES1 (0.56) | TGM2PDGFRBCES1MAOAMAOB | |
| SCHEMBL18793664 | 0.80 | TGM2 (0.44) | TGM2PDGFRBCA1CA2CA7 | |
| SCHEMBL19855795 | 0.75 | CES1 (0.71) | TGM2CES1AKR1A1AKR1B1 | |
| SCHEMBL11920847 | 0.75 | CES1 (0.50) | TGM2CA1CA2CA7CA9 | |
| SCHEMBL21708142 | 0.75 | TDP2 (0.46) | TGM2CES1 | |
| SCHEMBL8873796 | 0.72 | TGM2 (0.48) | TGM2PDGFRBCA1CA2CA7 | |
| SCHEMBL8873805 | 0.72 | TGM2 (0.48) | TGM2PDGFRBCA1CA2CA7 | |
| SCHEMBL8874231 | 0.72 | TGM2 (0.48) | TGM2PDGFRBCA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11114668-B2 | Electrode materials and processes for their preparation | HYDRO-QUéBEC (CA) | 2021-09-07 | — | — | US | disclosed |
| US-20200052302-A1 | ELECTRODE MATERIALS AND PROCESSES FOR THEIR PREPARATION | HYDRO-QUéBEC (CA) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052302-A1 | ELECTRODE MATERIALS AND PROCESSES FOR THEIR PREPARATION | ALPL, EPCAM, MB | TGM2 2347/4885PDGFRB 4588/4885CA1 1151/4885 |
| US-11114668-B2 | Electrode materials and processes for their preparation | ALPL, EPCAM, MB | TGM2 2347/4885PDGFRB 4588/4885CA1 1151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.